{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:11:51Z","timestamp":1789913511082,"version":"4.0.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>\n                      Diabetes mellitus is associated with increased risk of cognitive impairment. This study examines whether microvascular disease, as measured by albuminuria and decline in estimated GFR (eGFR), is associated with cognitive decline during 3.3 years of follow-up in individuals with diabetes with a normal baseline eGFR (approximately 90 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>\n                      Participants were from the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes study (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      =2977; mean age 62.5\u00b15.8 years; recruitment from August 2003 to December 2005, followed through June 2009), which examined the association of intensive versus standard glucose control on cognitive function. Participants underwent three neuropsychologic tests at baseline, 20 months, and 40 months. Tests included information processing speed, verbal memory, and executive function. Mixed-effects models were used to assess the association of albuminuria and eGFR on the percentage decline in each test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants with albuminuria at baseline and follow-up (persistent albuminuria) (\u22125.8% [95% confidence interval (CI), \u22127.3 to \u22124.2]) and participants with albuminuria at follow-up but none at baseline (progressive albuminuria) (\u22124.1% [95% CI, \u22125.6 to \u22122.7]) had greater percentage declines on information processing speed than participants without albuminuria at baseline and at follow-up (no albuminuria) (\u22122.6% [95% CI, \u22123.4 to \u22121.9]) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.001 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.10, respectively). There were borderline percentage changes in the test of verbal memory (4.8% [95% CI, 2.4 to 7.1] and 4.7% [95% CI, 2.5 to 7.0] versus 7.1% [95% CI, 6.0 to 8.3];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.11 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.08, respectively). On logistic regression analysis, persistent albuminuria (odds ratio, 1.37 [95% CI, 1.09 to 1.72]) and progressive albuminuria (odds ratio, 1.25 [95% CI, 1.02 to 1.56]) were associated with a \u22655% decline in information processing speed scores but not with verbal memory or executive function performance. A 1 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      per year eGFR decline had a borderline association with decline in tests of cognitive function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Persistent albuminuria and progressive albuminuria are associated with a decline in cognitive function in relatively young individuals with diabetes with unimpaired eGFR. These findings do not rule out the possibility of other processes causing cognitive decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.11321112","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:31:35Z","timestamp":1377822695000},"page":"1907-1914","source":"Crossref","is-referenced-by-count":53,"title":["Albuminuria and Cognitive Decline in People with Diabetes and Normal Renal Function"],"prefix":"10.2215","volume":"8","author":[{"given":"Joshua I.","family":"Barzilay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Lovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faramaz","family":"Ismail-Beigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Papademetriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore J.","family":"Launer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20230811","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1007\/s00125-005-0023-4","article-title":"Cognitive decline and dementia in diabetes\u2014systematic overview of prospective observational studies.","volume":"48","author":"Cukierman","year":"2005","journal-title":"Diabetologia"},{"key":"R2-12-20230811","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneurol.2012.1117","article-title":"Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.","volume":"69","author":"Yaffe","year":"2012","journal-title":"Arch Neurol"},{"key":"R3-12-20230811","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/01.ASN.0000131529.60019.FA","article-title":"Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study.","volume":"15","author":"Seliger","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R4-12-20230811","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.ajkd.2010.08.003","article-title":"Cognitive impairment in CKD: no longer an occult burden.","volume":"56","author":"Murray","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R6-12-20230811","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States.","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"R7-12-20230811","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","article-title":"Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III.","volume":"61","author":"Garg","year":"2002","journal-title":"Kidney Int"},{"key":"R8-12-20230811","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/archinternmed.2010.502","article-title":"Albuminuria and decline in cognitive function: The ONTARGET\/TRANSCEND studies.","volume":"171","author":"Barzilay","year":"2011","journal-title":"Arch Intern Med"},{"key":"R9-12-20230811","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2337\/dc11-0186","article-title":"Biomarkers of renal function and cognitive impairment in patients with diabetes.","volume":"34","author":"Murray","year":"2011","journal-title":"Diabetes Care"},{"key":"R10-12-20230811","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.ajkd.2007.12.044","article-title":"Albuminuria and dementia in the elderly: A community study.","volume":"52","author":"Barzilay","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R11-12-20230811","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/ki.2011.415","article-title":"Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.","volume":"81","author":"Ismail-Beigi","year":"2012","journal-title":"Kidney Int"},{"key":"R12-12-20230811","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MNH.0b013e3283293db1","article-title":"Early nephropathy in type 1 diabetes: The importance of early renal function decline.","volume":"18","author":"Perkins","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R13-12-20230811","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes.","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-12-20230811","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Design and methods.","volume":"99","author":"Buse","year":"2007","journal-title":"Am J Cardiol"},{"key":"R15-12-20230811","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus.","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"key":"R16-12-20230811","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus.","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"R18-12-20230811","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy.","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurol"},{"key":"R19-12-20230811","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000026246","article-title":"CASCADE: A European collaborative study on vascular determinants of brain lesions. Study design and objectives.","volume":"19","author":"Launer","year":"2000","journal-title":"Neuroepidemiology"},{"key":"R21-12-20230811","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1037\/0882-7974.19.1.211","article-title":"Adult age and digit symbol substitution performance: A meta-analysis.","volume":"19","author":"Hoyer","year":"2004","journal-title":"Psychol Aging"},{"key":"R23-12-20230811","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/03610739308253934","article-title":"Stroop interference: Aging effects assessed with the Stroop Color-Word Test.","volume":"19","author":"Houx","year":"1993","journal-title":"Exp Aging Res"},{"key":"R24-12-20230811","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population-based norms for the Mini-Mental State Examination by age and educational level.","volume":"269","author":"Crum","year":"1993","journal-title":"JAMA"},{"key":"R25-12-20230811","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.","volume":"307","author":"Matsushita","year":"2012","journal-title":"JAMA"},{"key":"R27-12-20230811","first-page":"4","article-title":"The physiology of bone blood flow: A review.","volume":"88","author":"McCarthy","year":"2006","journal-title":"J Bone Joint Surg Am"},{"key":"R28-12-20230811","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.STR.0000254517.04275.3f","article-title":"Endothelial function and white matter hyperintensities in older adults with cardiovascular disease.","volume":"38","author":"Hoth","year":"2007","journal-title":"Stroke"},{"key":"R29-12-20230811","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1681\/ASN.2010111181","article-title":"Estimated GFR, albuminuria, and complications of chronic kidney disease.","volume":"22","author":"Inker","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R30-12-20230811","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.psychres.2011.11.012","article-title":"Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer\u2019s disease.","volume":"196","author":"Sattler","year":"2012","journal-title":"Psychiatry Res"},{"key":"R31-12-20230811","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Practice parameter: early detection of dementia: Mild cognitive impairment (an evidence-based review).","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology"},{"key":"R32-12-20230811","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/aje\/kwk017","article-title":"Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies.","volume":"165","author":"Proust-Lima","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R33-12-20230811","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2337\/dc12-0746","article-title":"Effects of type 2 diabetes on 12-year cognitive change: Results from the Maastricht aging study.","volume":"36","author":"Spauwen","year":"2013","journal-title":"Diabetes Care"},{"key":"R34-12-20230811","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000333076","article-title":"Albuminuria and cognitive functioning in an older population: The Hoorn study.","volume":"32","author":"Heringa","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R35-12-20230811","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/aje\/kwp426","article-title":"A prospective study of albuminuria and cognitive function in older adults: The Rancho Bernardo study.","volume":"171","author":"Jassal","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R36-12-20230811","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1053\/j.ajkd.2008.08.022","article-title":"Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.","volume":"53","author":"Weiner","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R37-12-20230811","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2215\/CJN.05530610","article-title":"Association of cognitive function with albuminuria and eGFR in the general population.","volume":"6","author":"Joosten","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R38-12-20230811","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1681\/ASN.2005010005","article-title":"Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study.","volume":"16","author":"Kurella","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R39-12-20230811","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2006101165","article-title":"Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III).","volume":"18","author":"Hailpern","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R40-12-20230811","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0b013e3181b72629","article-title":"Kidney function is associated with the rate of cognitive decline in the elderly.","volume":"73","author":"Buchman","year":"2009","journal-title":"Neurology"},{"key":"R41-12-20230811","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/ndt\/gfp230","article-title":"Chronic kidney disease is associated with incident cognitive impairment in the elderly: The INVADE study.","volume":"24","author":"Etgen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R42-12-20230811","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1212\/WNL.0b013e31823b4765","article-title":"Chronic kidney disease, cognitive decline, and incident dementia: The 3C Study.","volume":"77","author":"Helmer","year":"2011","journal-title":"Neurology"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201311000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:38Z","timestamp":1786369418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201311000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11321112","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}